Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution

被引:185
作者
Hohenester, E
Sasaki, T
Olsen, BR
Timpl, R
机构
[1] Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England
[2] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[3] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
关键词
angiogenesis inhibitor; collagen; crystal structure; heparin binding;
D O I
10.1093/emboj/17.6.1656
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of extracellular proteins contain cryptic inhibitors of angiogenesis. Endostatin is a 20 kDa C-terminal proteolytic fragment of collagen XVIII that potently inhibits endothelial cell proliferation and angiogenesis. Therapy of experimental cancer with endostatin leads to tumour dormancy and does not induce resistance, We have expressed recombinant mouse endostatin and determined its crystal structure at 1.5 Angstrom resolution. The structure reveals a compact fold distantly related to the C-type lectin carbohydrate recognition domain and the hyaluronan-binding Link module. The high affinity of endostatin for heparin is explained by the presence of an extensive basic patch formed by 11 arginine residues. Endostatin may inhibit angiogenesis by binding to the heparan sulphate proteoglycans involved in growth factor signalling.
引用
收藏
页码:1656 / 1664
页数:9
相关论文
共 49 条
[1]  
[Anonymous], ACTA CRYSTALLOGR D
[2]   Vascular development: Cellular and molecular regulation [J].
Beck, L ;
DAmore, PA .
FASEB JOURNAL, 1997, 11 (05) :365-373
[3]   Crystal structure of human lithostathine, the pancreatic inhibitor of stone formation [J].
Bertrand, JA ;
Pignol, D ;
Bernard, JP ;
Verdier, JM ;
Dagorn, JC ;
FontecillaCamps, JC .
EMBO JOURNAL, 1996, 15 (11) :2678-2684
[4]   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[5]   Structure and distribution of modules in extracellular proteins [J].
Bork, P ;
Downing, AK ;
Kieffer, B ;
Campbell, ID .
QUARTERLY REVIEWS OF BIOPHYSICS, 1996, 29 (02) :119-167
[6]   HISTIDINE-RICH GLYCOPROTEIN AND PLATELET FACTOR-4 MASK HEPARAN-SULFATE PROTEOGLYCANS RECOGNIZED BY ACIDIC AND BASIC FIBROBLAST GROWTH-FACTOR [J].
BROWN, KJ ;
PARISH, CR .
BIOCHEMISTRY, 1994, 33 (46) :13918-13927
[7]  
Brunger A. T., 1992, X PLOR VERSION 3 1 S
[8]   Molecular mechanisms of blood vessel formation [J].
Bussolino, F ;
Mantovani, A ;
Persico, G .
TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (07) :251-256
[9]   THE 16-KILODALTON N-TERMINAL FRAGMENT OF HUMAN PROLACTIN IS A POTENT INHIBITOR OF ANGIOGENESIS [J].
CLAPP, C ;
MARTIAL, JA ;
GUZMAN, RC ;
RENTIERDELRUE, F ;
WEINER, RI .
ENDOCRINOLOGY, 1993, 133 (03) :1292-1299
[10]   Phase combination and cross validation in iterated density-modification calculations [J].
Cowtan, KD ;
Main, P .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1996, 52 :43-48